Free Trial

Bayesian Capital Management LP Invests $440,000 in Ingredion Incorporated (NYSE:INGR)

Ingredion logo with Consumer Staples background

Bayesian Capital Management LP purchased a new stake in Ingredion Incorporated (NYSE:INGR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,200 shares of the company's stock, valued at approximately $440,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of INGR. Benjamin Edwards Inc. increased its position in shares of Ingredion by 4.4% during the fourth quarter. Benjamin Edwards Inc. now owns 10,235 shares of the company's stock worth $1,408,000 after purchasing an additional 430 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of Ingredion by 101.1% during the fourth quarter. BNP Paribas Financial Markets now owns 99,027 shares of the company's stock worth $13,622,000 after purchasing an additional 49,790 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Ingredion by 9.8% during the fourth quarter. Ameriprise Financial Inc. now owns 158,346 shares of the company's stock worth $21,782,000 after purchasing an additional 14,178 shares in the last quarter. Algert Global LLC acquired a new stake in shares of Ingredion during the fourth quarter worth about $12,720,000. Finally, AXA S.A. increased its position in shares of Ingredion by 31.8% during the fourth quarter. AXA S.A. now owns 24,055 shares of the company's stock worth $3,309,000 after purchasing an additional 5,804 shares in the last quarter. 85.27% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have weighed in on INGR. Oppenheimer lowered their price objective on Ingredion from $167.00 to $155.00 and set an "outperform" rating on the stock in a report on Tuesday, April 22nd. UBS Group set a $155.00 price objective on Ingredion in a report on Tuesday, April 22nd. BMO Capital Markets lowered their price objective on Ingredion from $147.00 to $133.00 and set a "market perform" rating on the stock in a report on Wednesday, February 5th. Stephens lowered their price objective on Ingredion from $155.00 to $150.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 5th. Finally, StockNews.com lowered Ingredion from a "strong-buy" rating to a "buy" rating in a report on Thursday, February 6th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $152.20.

View Our Latest Stock Report on INGR

Ingredion Price Performance

Shares of NYSE:INGR traded down $0.12 during trading on Monday, hitting $137.04. 68,695 shares of the stock were exchanged, compared to its average volume of 467,590. The company has a fifty day moving average price of $131.72 and a two-hundred day moving average price of $135.59. The company has a market cap of $8.81 billion, a PE ratio of 14.11, a P/E/G ratio of 1.03 and a beta of 0.73. The company has a current ratio of 2.62, a quick ratio of 1.69 and a debt-to-equity ratio of 0.47. Ingredion Incorporated has a 12-month low of $111.54 and a 12-month high of $155.44.

Ingredion (NYSE:INGR - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $2.97 EPS for the quarter, topping the consensus estimate of $2.44 by $0.53. The business had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.84 billion. Ingredion had a return on equity of 18.62% and a net margin of 8.71%. The company's quarterly revenue was down 3.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.08 EPS. On average, analysts forecast that Ingredion Incorporated will post 11.14 EPS for the current year.

Ingredion Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 22nd. Shareholders of record on Tuesday, April 1st were issued a $0.80 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $3.20 annualized dividend and a yield of 2.34%. Ingredion's dividend payout ratio (DPR) is presently 33.76%.

Insider Buying and Selling at Ingredion

In other Ingredion news, CEO James P. Zallie sold 10,815 shares of the business's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $125.88, for a total value of $1,361,392.20. Following the completion of the transaction, the chief executive officer now directly owns 34,127 shares in the company, valued at approximately $4,295,906.76. The trade was a 24.06% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Larry Fernandes sold 2,400 shares of the business's stock in a transaction on Wednesday, May 7th. The shares were sold at an average price of $135.82, for a total value of $325,968.00. Following the completion of the transaction, the senior vice president now owns 31,996 shares of the company's stock, valued at $4,345,696.72. This trade represents a 6.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 13,215 shares of company stock worth $1,687,360. Insiders own 2.30% of the company's stock.

Ingredion Profile

(Free Report)

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.

See Also

Institutional Ownership by Quarter for Ingredion (NYSE:INGR)

Should You Invest $1,000 in Ingredion Right Now?

Before you consider Ingredion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.

While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines